Product Information
PHENOBARBITAL 16.2 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0559 per EA under NDC 16571067101. Its NADAC has been published 270 times since Aug 4, 2021.
Strength
16.2 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571067101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
11/1/2020
Price Statistics
The NADAC for PHENOBARBITAL 16.2 MG TABLET has been published 270 times since Aug 4, 2021, and over the history we have for it it has declined 77.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0559 per EA |
|---|---|
| All-time high | $0.2730 (Sep 14, 2022) |
| All-time low | $0.0483 (Jun 17, 2026) |
| 52-week high | $0.0692 |
| 52-week low | $0.0483 |
| Median price | $0.1374 |
| Average price | $0.1441 |
| Largest weekly change | +149.4% (Jun 19, 2024) |
| Weeks tracked | 270 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phenobarbital market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 16.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 16.2 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0559 per EA (NDC 16571067101), effective Sep 30, 2026.
How has the price of PHENOBARBITAL 16.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 16.2 MG TABLET has declined 77.7%. It has been tracked across 270 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 16.2 MG TABLET?
Since Aug 4, 2021, the NADAC for PHENOBARBITAL 16.2 MG TABLET has ranged from a low of $0.0483 (Jun 17, 2026) to a high of $0.2730 (Sep 14, 2022), with a median of $0.1374 per EA.
Are there cheaper alternatives to PHENOBARBITAL 16.2 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PHENOBARBITAL 16.2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PHENOBARBITAL 16.2 MG TABLET?
PHENOBARBITAL 16.2 MG TABLET (NDC 16571067101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.